Handok Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Handok Inc. - Product Pipeline Review - 2014', provides an overview of the Handok Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Handok Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Handok Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Handok Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Handok Inc.'s pipeline products Reasons to buy - Evaluate Handok Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Handok Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Handok Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Handok Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Handok Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Handok Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Handok Inc. Snapshot 5 Handok Inc. Overview 5 Key Information 5 Key Facts 5 Handok Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Handok Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Handok Inc. - Pipeline Products Glance 12 Handok Inc. - Late Stage Pipeline Products 12 Pre-Registration Products/Combination Treatment Modalities 12 Handok Inc. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Handok Inc. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Handok Inc. - Drug Profiles 17 teneligliptin 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 ozarelix 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 HL-1513 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 HL-2351 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 HL-2353 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 HL-5201 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 HL-5501 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 HL-3501 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 HL-5171 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 HL-5511 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Handok Inc. - Pipeline Analysis 29 Handok Inc. - Pipeline Products by Target 29 Handok Inc. - Pipeline Products by Route of Administration 30 Handok Inc. - Pipeline Products by Molecule Type 31 Handok Inc. - Pipeline Products by Mechanism of Action 32 Handok Inc. - Recent Pipeline Updates 33 Handok Inc. - Dormant Projects 34 Handok Inc. - Locations And Subsidiaries 35 Head Office 35 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us 37 Disclaimer 37
List of Tables Handok Inc., Key Information 5 Handok Inc., Key Facts 5 Handok Inc. - Pipeline by Indication, 2014 7 Handok Inc. - Pipeline by Stage of Development, 2014 8 Handok Inc. - Monotherapy Products in Pipeline, 2014 9 Handok Inc. - Partnered Products in Pipeline, 2014 10 Handok Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11 Handok Inc. - Pre-Registration, 2014 12 Handok Inc. - Phase II, 2014 13 Handok Inc. - Phase I, 2014 14 Handok Inc. - Preclinical, 2014 15 Handok Inc. - Discovery, 2014 16 Handok Inc. - Pipeline by Target, 2014 29 Handok Inc. - Pipeline by Route of Administration, 2014 30 Handok Inc. - Pipeline by Molecule Type, 2014 31 Handok Inc. - Pipeline Products by Mechanism of Action, 2014 32 Handok Inc. - Recent Pipeline Updates, 2014 33 Handok Inc. - Dormant Developmental Projects,2014 34
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.